Idera Pharmaceuticals, Inc.

NASDAQ:IDRA   12:59:24 AM EDT
0.37
+0.01 (+2.57%)
1:53:49 PM EDT: $0.38 +0.01 (+3.81%)
Earnings Announcements

Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:41 GMT
Idera Pharmaceuticals, Inc. (IDRA) - Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Idera Pharmaceuticals Inc - Qtrly Net Loss per Basic $0.06.
Idera Pharmaceuticals Inc - Expects to Initiate Advance Clinical Study for Acg-801 in Farber Disease in 2h 2023 With Data Expected in Q1 2024.
Idera Pharmaceuticals Inc - Advance Study is on Track for Initiation in Second Half of 2023.